{"data":{"id":1005,"lang":"en","title":"New Four-Marker Blood Test Detects Pancreatic Cancer With 92% Accuracy, Even in Early Stages","summary":"UPenn and Mayo Clinic researchers developed a four-biomarker blood test that detects pancreatic cancer with 91.9% accuracy, catching 87.5% of early-stage cases.","category":"science","category_label":"Science","published_at":"2026-03-24T00:01:56Z","updated_at":"2026-03-24T00:01:56Z","url":"https://techtools.cz/tools/news/article/1005-new-four-marker-blood-test-detects-pancreatic-cancer-with-92-accuracy-even-in","api_url":"https://techtools.cz/news-api/v1/articles/1005?lang=en","markdown_url":"https://techtools.cz/news-api/v1/articles/1005.md?lang=en","image_url":"https://www.nih.gov/sites/default/files/2026-02/20260224-pancreatic-test.jpg","word_count":111,"reading_time_minutes":1,"sources":[{"url":"https://www.sciencedaily.com/releases/2026/03/260323005540.htm","domain":"sciencedaily.com"},{"url":"https://www.nih.gov/news-events/nih-research-matters/progress-toward-blood-test-early-pancreatic-cancer","domain":"nih.gov"}],"translation":{"lang":"cs","id":1040,"title":"Nový krevní test se čtyřmi markery odhalí rakovinu slinivky s 92% přesností, i v raných stádiích","url":"https://techtools.cz/tools/news/clanek/1040-novy-krevni-test-se-ctyrmi-markery-odhali-rakovinu-slinivky-s-92-presnosti-i-v","api_url":"https://techtools.cz/news-api/v1/articles/1040?lang=cs"},"content":"Researchers at the University of Pennsylvania and Mayo Clinic have developed a blood test that detects pancreatic cancer with 91.9% accuracy by combining four protein biomarkers. The test identified 87.5% of early-stage (I/II) cases — a critical advance for a disease where only 1 in 10 patients survive beyond five years due to late diagnosis.\n\nLead researcher Dr. Kenneth Zaret's team studied 672 individuals and identified two new blood markers — aminopeptidase N (ANPEP) and polymeric immunoglobulin receptor (PIGR) — that, when combined with existing markers CA19-9 and THBS2, dramatically improved detection. The test maintained just a 5% false positive rate and successfully distinguished cancer patients from those with non-cancerous conditions like pancreatitis."}}